Skip to main content
. Author manuscript; available in PMC: 2022 Mar 1.
Published in final edited form as: J Comp Neurol. 2020 Aug 13;529(4):885–904. doi: 10.1002/cne.24986

TABLE 1.

Subjects and injection sites: Summary of the injection sites for each subject showing the total volume injected and the rostro-caudal extent of the core for each injection

EC injection 3 + 10 kDA
(5% sol, 3 μl)
AMY injection 3 + 10 kDA
(5% sol, 3 μl)
dPMC injection 3 + 10 kDA
(5% sol, 4 μl)
Case Sex, age Tracer analysis R-C extent Tracer analysis R-C extent AMY nucleus Tracer analysis R-C extent
PIJ M, 5 FE (bidir.) 0.3 mm n/a FR (bidir.) 0.3 mm
PIK M, 7 n/a FR (bidir.) 1.2 mm Basolateral FE (bidir.) 1.5 mm
PIL M, 7 n/a FR (bidir.) 0.3 mm Lateral FE (bidir.) 0.6 mm
PIM F, 6 CBL (bidir.) 0.3 mm FR (bidir.) 0.6 mm Basomedial FE (retro) 0.3 mm
PIN F, 6 CBL (bidir.) 0.6 mm FR (retro) 0.6 mm Cortical n/a

Note: Monkeys received injections of bidirectional tracers, fluoroemerald (FE), fluororuby (FR), or Cascade blue (CBL) in the entorhinal cortex (EC), amygdala (AMY), and dorsal pre-motor cortex (dPMC). For all injections a 1:1 cocktail of 10kDA and 3 kDa isotopes for bidirectional tracing was used, with each dye diluted to final concentration of 5% in sterile water. Some cases were used for retrograde (retro) analyses only, or bidirectional (bidir.) analyses of anterograde and retrograde label